Selective Antibiotic Prophylaxis in Oncologic Skin Graft Reconstruction
Journal of Plastic, Reconstructive & Aesthetic Surgery · 2026-10
DOI: 10.1016/j.bjps.2026.10.044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Plastic, Reconstructive & Aesthetic Surgery, 2026-10. Verfasst von Lasse Østrup Petersen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Breast Surgery, Aarhus University Hospital, Aarhus, Denmark. Electronic address: lasse.oe.petersen@gmail.com. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Skin grafting is frequently required after oncologic skin cancer excision when direct closure or local flaps are not feasible. Surgical site infection (SSI) is a major cause of graft failure; however, the role of prophylactic oral antibiotics remains uncertain. METHODS: This retrospective cohort study included 750 consecutively enrolled patients who underwent skin graft reconstruction after skin cancer excision between January 2021 and December 2023. Patient characteristics, graft type, tumor location, prophylactic oral antibiotic use, and postoperative SSI were recorded. Associations between SSI, prophylactic antibiotic use, and graft take were evaluated using multivariable ordinal and binary logistic regression analyses. RESULTS: The mean patient age was 77 years, and 63% were male. Prophylactic oral antibiotics were administered in 226 patients (30.1%), most commonly dicloxacillin for 5-7 days. Overall, 119 patients (15.9%) developed an SSI. SSI was strongly associated with worse graft outcomes (odds ratio [OR], 16.81; 95% confidence intervals [CI], 10.95-25.80). Prophylactic antibiotic use was independently associated with lower odds of SSI (OR, 0.15; 95% CI, 0.08-0.30). Prophylaxis was also associated with better graft outcomes in ordinal regression analysis (OR, 0.67; 95% CI, 0.47-0.97); however, secondary analyses showed lower odds of complete graft loss but no significant association with any graft loss. CONCLUSIONS: SSI is associated with impaired graft take following oncologic reconstruction. Prophylactic oral antibiotics were associated with lower odds of SSI and better graft outcomes, suggesting a potential benefit of selective prophylaxis. Given the retrospective design and potential for residual confounding, prospective studies are warranted to confirm these findings and determine the optimal prophylactic regimen.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Plastic and Breast Surgery, Aarhus University Hospital, Aarhus, Denmark. Electronic address: lasse.oe.petersen@gmail.com.
- Department of Plastic and Breast Surgery, Aarhus University Hospital, Aarhus, Denmark.
- Department of Plastic and Breast Surgery, Aarhus University Hospital, Aarhus, Denmark; Department of Breast and Plastic Surgery, Aalborg University Hospital, Aalborg, Denmark.
Zitieren
APA
Petersen, L. Ø., Mensel, C., Munk, K. W., Rautio, E., Stern, M., Bønnelykke-Behrndtz, L., Hasanbegovic, E., & Alstrup, T. (2026). Selective Antibiotic Prophylaxis in Oncologic Skin Graft Reconstruction. Journal of Plastic, Reconstructive & Aesthetic Surgery. https://doi.org/10.1016/j.bjps.2026.10.044
Vancouver
Petersen LØ, Mensel C, Munk KW, Rautio E, Stern M, Bønnelykke-Behrndtz L, et al. Selective Antibiotic Prophylaxis in Oncologic Skin Graft Reconstruction. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2026. doi:10.1016/j.bjps.2026.10.044
BibTeX
@article{Petersen2026,
author = {Petersen, Lasse Østrup and Mensel, Camilla and Munk, Kathrine Wulf and Rautio, Emil and Stern, Mette and Bønnelykke-Behrndtz, Louise and Hasanbegovic, Emir and Alstrup, Toke},
title = {Selective Antibiotic Prophylaxis in Oncologic Skin Graft Reconstruction},
journal = {Journal of Plastic, Reconstructive & Aesthetic Surgery},
year = {2026},
doi = {10.1016/j.bjps.2026.10.044}
}
EUVIMED